The microorganism Escherichia coli is usually used for recombinant protein manufacturing. Regardless of a number of advantageous traits like quick development and excessive protein yields, its incapability to simply secrete recombinant proteins into the extracellular medium stays a disadvantage for industrial manufacturing processes. To beat this limitation, a large number of approaches to reinforce the extracellular yield and the secretion effectivity of recombinant proteins have been developed in recent times.
Right here, a complete overview of secretion mechanisms for recombinant proteins from E. coli is given and divided into three fundamental sections. First, the construction of the E. coli cell envelope and the identified pure secretion programs are described. Second, the use and optimization of various one- or two-step secretion programs for recombinant protein manufacturing, in addition to additional permeabilization strategies are mentioned.
Lastly, the often-overlooked position of cell lysis in secretion research and its evaluation are addressed. Thus far, efficient approaches for rising the extracellular protein focus to greater than 10 g/L and virtually 100% secretion effectivity exist, nevertheless, the big vary of optimization strategies and their combos means that the potential for secretory protein manufacturing from E. coli has not but been totally realized.
Scalable Excessive-Efficiency Manufacturing of Recombinant Horseradish Peroxidase from E. coli Inclusion Our bodies
Horseradish peroxidase (HRP), an enzyme omnipresent in biotechnology, remains to be produced from furry root cultures, though this process is time-consuming and solely offers low yields. As well as, the plant-derived enzyme preparation consists of a variable combination of isoenzymes with excessive batch-to-batch variation stopping its use in therapeutic functions. On this research, we current a novel and scalable recombinant HRP manufacturing course of in Escherichia coli that yields a extremely pure, energetic and homogeneous single isoenzyme.
We efficiently developed a multi-step inclusion physique course of giving a last yield of 960 mg energetic HRP/L tradition medium with a purity of ≥99% decided by size-exclusion high-performance liquid chromatography (SEC-HPLC). The Reinheitszahl, in addition to the exercise with 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) and three,3′,5,5′-tetramethylbenzidine (TMB) as lowering substrates, are akin to commercially out there plant HRP. Thus, our preparation of recombinant, unglycosylated HRP from E. coli is a viable various to the enzyme from plant and extremely attention-grabbing for therapeutic functions.
Efficient Allitol Bioproduction from D-Fructose Catalyzed by Recombinant E. coli Complete Cells, and the Situation Optimization, Product Purification
Allitol is a sort of uncommon sugar alcohol with potential utility worth. An engineered pressure, which concurrently expressed D-psicose-3-epimerase (DPE), ribitol dehydrogenase (RDH), and formate dehydrogenase (FDH) three enzymes, was constructed by cloning above three genes into one plasmid and remodeled into the host E. coli pressure, and used because the whole-cell catalysts for biotransformation of allitol from the low-cost substrate of D-fructose. The entire cell allitol biotransformation circumstances have been optimized.
The medium, recombinant gene induction circumstances, and the substrate feeding fee for cultivation of the catalytic cells have been optimized. Then, the fed-batch tradition was made and scaled as much as 10 L fermentor. Lastly, 63.44 g/L allitol was obtained from 100 g/L D-fructose after Three h of biotransformation, and the allitol crystals of 99.9% purity have been obtained through the use of cooling recrystallization. The allitol manufacturing methodology developed on this analysis has excessive product purity, and is very environment friendly, simply scaled up, and appropriate for large-scale manufacturing of extremely purified allitol.
Scalable, two-stage, autoinduction of recombinant protein expression in E. coli using phosphate depletion
We report the scalable manufacturing of recombinant proteins in Escherichia coli, reliant on tightly managed autoinduction, triggered by phosphate depletion within the stationary section. The strategy, reliant on engineered strains and plasmids, allows improved protein expression throughout scales. Expression ranges utilizing this strategy have reached as excessive as 55% of the full mobile protein.

The preliminary use of the tactic in instrumented fed-batch fermentations allows cell densities of ∼30 gCDW/L and protein titers as much as 8.1 ± 0.7 g/L (∼270 mg/gCDW). The method has additionally been tailored to an optimized autoinduction media, enabling routine batch manufacturing at tradition volumes of 20 μl (384-well plates), 100 μl (96-well plates), 20 ml, and 100 ml. In batch cultures, cell densities routinely attain ∼5-7 gCDW/L, providing protein titers above 2 g/L. The methodology has been validated with a set of numerous heterologous proteins and is of basic use for the facile optimization of routine protein expression from excessive throughput screens to fed-batch fermentation.
A simplified methodology for producing laboratory grade recombinant TEV protease from E. coli.
The tobacco etch virus (TEV) protease has develop into a preferred selection for cleaving fusion proteins due to its excessive stringency in sequence recognition. Procedures for isolating recombinant protein from the cytoplasm of E. coli require rupturing of the cell wall by way of enzymatic therapy mixed with sonication or French press.
E. coli RuvC protein |
01-011 |
Sceti |
50 ug |
EUR 574.8 |
Description: The E. coli RuvC protein is available in Europe and for worldwide shipping via Gentaur. |
E. coli RuvC protein |
01-012 |
Sceti |
250 ug |
EUR 1420.8 |
Description: The E. coli RuvC protein is available in Europe and for worldwide shipping via Gentaur. |
RecA Protein E. coli |
M1231-200 |
Biovision |
each |
EUR 242.4 |
Escherichia coli (E. coli) Antibody |
abx415692-01mg |
Abbexa |
0.1 mg |
EUR 760.8 |
|
Escherichia coli (E. coli) Antibody |
abx415712-1ml |
Abbexa |
1 ml |
EUR 727.2 |
|
Escherichia coli (E. coli) Antibody |
abx411320-1ml |
Abbexa |
1 ml |
EUR 610.8 |
|
E. coli antibody |
10-E09C |
Fitzgerald |
100 ug |
EUR 159.6 |
Description: Mouse monoclonal E. coli antibody |
E. coli antibody |
10-E10A |
Fitzgerald |
500 ug |
EUR 591.6 |
Description: Mouse monoclonal E. coli antibody |
E. coli antibody |
10-E10B |
Fitzgerald |
500 ug |
EUR 591.6 |
Description: Mouse monoclonal E. coli antibody |
E. coli antibody |
20C-CR1244GP |
Fitzgerald |
1 ml |
EUR 561.6 |
Description: Goat polyclonal E. coli antibody |
E. coli antibody |
20-ER13 |
Fitzgerald |
1 ml |
EUR 426 |
Description: Rabbit polyclonal E. coli antibody |
E. coli antibody |
10C-CR1244M1 |
Fitzgerald |
100 ug |
EUR 489.6 |
Description: Mouse monoclonal E. coli antibody |
E. coli Antibody |
abx021669-1mg |
Abbexa |
1 mg |
EUR 1554 |
|
E. coli Antibody |
abx021670-1mg |
Abbexa |
1 mg |
EUR 1045.2 |
|
E. coli Antibody |
abx021671-02ml |
Abbexa |
0.2 ml |
EUR 594 |
|
E. coli Antibody |
abx021672-1mg |
Abbexa |
1 mg |
EUR 1045.2 |
|
E. coli Antibody |
abx021673-1mg |
Abbexa |
1 mg |
EUR 1045.2 |
|
E. coli Antibody |
abx022970-1ml |
Abbexa |
1 ml |
EUR 878.4 |
|
E. coli Antibody |
abx022971-1ml |
Abbexa |
1 ml |
EUR 1161.6 |
|
E. coli Antibody |
abx022975-1ml |
Abbexa |
1 ml |
EUR 718.8 |
|
E. coli Antibody |
abx022977-1ml |
Abbexa |
1 ml |
EUR 811.2 |
|
Recombinant Trypanosoma Cruzi Shed-acute-phase-antigen Protein (aa 61-460) (E. coli) [His] |
VAng-Wyb8480-100g |
Creative Biolabs |
100 µg |
EUR 4002 |
Description: Trypanosoma Cruzi Shed-acute-phase-antigen protein, recombinant protein. |
Recombinant Trypanosoma Cruzi Shed-acute-phase-antigen Protein (aa 61-460) (E. coli) [His] |
VAng-Wyb8480-500g |
Creative Biolabs |
500 µg |
EUR 9794.4 |
Description: Trypanosoma Cruzi Shed-acute-phase-antigen protein, recombinant protein. |
Escherichia coli (E. coli) Antibody (Biotin) |
abx415713-1ml |
Abbexa |
1 ml |
EUR 861.6 |
|
Escherichia coli (E. coli) Antibody (Biotin) |
abx411321-1ml |
Abbexa |
1 ml |
EUR 710.4 |
|
Escherichia coli (E. coli) Antibody (FITC) |
abx411322-1ml |
Abbexa |
1 ml |
EUR 610.8 |
|
E. Coli O 157 Protein |
abx061475-01ml |
Abbexa |
0.1 ml |
EUR 661.2 |
|
E. coli antibody (FITC) |
60-E13 |
Fitzgerald |
1 ml |
EUR 453.6 |
Description: Rabbit polyclonal E. coli antibody (FITC) conjugated |
E. coli antibody (biotin) |
60-E13B |
Fitzgerald |
1 ml |
EUR 561.6 |
Description: Rabbit polyclonal E. coli antibody (biotin) conjugated |
E. coli antibody (HRP) |
60-E14 |
Fitzgerald |
1 ml |
EUR 489.6 |
Description: Rabbit polyclonal E. coli antibody (HRP) conjugated |
E. coli O157 antibody |
10-1490 |
Fitzgerald |
100 ug |
EUR 163.2 |
Description: Mouse monoclonal E. coli O157 antibody |
E. coli O157 antibody |
10-1521 |
Fitzgerald |
100 ug |
EUR 170.4 |
Description: Mouse monoclonal E. coli O157 antibody |
E. coli O157 antibody |
10-E12A |
Fitzgerald |
100 ug |
EUR 462 |
Description: Mouse monoclonal E. coli O157 antibody |
E. coli DnaJ Antibody |
32022-05111 |
AssayPro |
150 ug |
EUR 313.2 |
E. coli pykF Antibody |
32163-05111 |
AssayPro |
150 ug |
EUR 313.2 |
E. coli GOR Antibody |
32540-05111 |
AssayPro |
150 ug |
EUR 313.2 |
E. coli CysH Antibody |
30281-05111 |
AssayPro |
150 ug |
EUR 313.2 |
E. Coli HCP antibody |
20R-EG001 |
Fitzgerald |
1 ml |
EUR 1004.4 |
Description: Goat polyclonal E. Coli HCP antibody |
E. coli NDK Antibody |
32662-05111 |
AssayPro |
150 ug |
EUR 313.2 |
E. coli PPA Antibody |
32678-05111 |
AssayPro |
150 ug |
EUR 313.2 |
E. coli glk Antibody |
32864-05111 |
AssayPro |
150 ug |
EUR 313.2 |
E. Coli ldhA Antibody |
32898-05111 |
AssayPro |
150 ug |
EUR 313.2 |
E. coli deoC Antibody |
32936-05111 |
AssayPro |
150 ug |
EUR 313.2 |
E. coli Skp Antibody |
32971-05111 |
AssayPro |
150 ug |
EUR 313.2 |
E. coli nanA Antibody |
33092-05111 |
AssayPro |
150 ug |
EUR 313.2 |
E. coli O157 antibody |
10C-CR1295M3 |
Fitzgerald |
100 ug |
EUR 470.4 |
Description: Mouse monoclonal E. coli O157 antibody |
E. coli LexA repressor |
01-005 |
Sceti |
50 ug |
EUR 574.8 |
Description: The E. coli LexA repressor is available in Europe and for worldwide shipping via Gentaur. |
E. coli LexA repressor |
01-006 |
Sceti |
250 ug |
EUR 1420.8 |
Description: The E. coli LexA repressor is available in Europe and for worldwide shipping via Gentaur. |
TesA, E. coli esterase |
0306-1 |
AthenaES |
100 Units |
EUR 505.2 |
TesA, E. coli esterase |
0306-5 |
AthenaES |
500 Units |
EUR 2046 |
E. coli GroEL Antibody |
20012-05011 |
AssayPro |
150 ug |
EUR 260.4 |
E. coli O157 Antibody |
abx021684-1mg |
Abbexa |
1 mg |
EUR 1220.4 |
|
E. coli O157 Antibody |
abx021685-1mg |
Abbexa |
1 mg |
EUR 1195.2 |
|
E. coli O157 Antibody |
abx021686-1mg |
Abbexa |
1 mg |
EUR 1195.2 |
|
E. coli O157 Antibody |
abx021687-1mg |
Abbexa |
1 mg |
EUR 1195.2 |
|
E. coli O157 Antibody |
abx021688-1mg |
Abbexa |
1 mg |
EUR 1128 |
|
E. coli O157 Antibody |
abx021689-1mg |
Abbexa |
1 mg |
EUR 1195.2 |
|
E. coli Antibody (HRP) |
abx022972-1ml |
Abbexa |
1 ml |
EUR 718.8 |
|
E. coli Antibody (FITC) |
abx022974-1ml |
Abbexa |
1 ml |
EUR 777.6 |
|
E. coli Antibody (Biotin) |
abx022976-1ml |
Abbexa |
1 ml |
EUR 718.8 |
|
E. coli Antibody (HRP) |
abx022978-1ml |
Abbexa |
1 ml |
EUR 1053.6 |
|
E. coli Antibody (Biotin) |
abx022979-1ml |
Abbexa |
1 ml |
EUR 886.8 |
|
E. coli O157 Antibody |
abx024017-1mg |
Abbexa |
1 mg |
EUR 1212 |
|
E. coli O 157 |
abx291002-100mg |
Abbexa |
100 mg |
EUR 744 |
|
Enterotoxin STp (E. coli) |
H-6248.0500 |
Bachem |
0.5mg |
EUR 835.2 |
Description: Sum Formula: C81H110N20O26S6; CAS# [115474-04-9] net |
Enterotoxin STp (E. coli) |
H-6248.1000 |
Bachem |
1.0mg |
EUR 1416 |
Description: Sum Formula: C81H110N20O26S6; CAS# [115474-04-9] net |
E. coli Topoisomerase IV |
TG2000EC-1 |
TopoGen |
250 units |
EUR 537.6 |
E. coli Topoisomerase IV |
TG2000EC-3 |
TopoGen |
500 units |
EUR 819.6 |
E. coli Topoisomerase IV |
TG2000EC-5 |
TopoGen |
1000 units |
EUR 1262.4 |
E. coli DNA Gyrase |
TG2000G-1 |
TopoGen |
100 units |
EUR 388.8 |
E. coli DNA Gyrase |
TG2000G-3 |
TopoGen |
500 units |
EUR 846 |
E. coli DNA Gyrase |
TG2000G-5 |
TopoGen |
1000 units |
EUR 1396.8 |
E. coli DNA Gyrase |
TG2000G-7 |
TopoGen |
2000 units |
EUR 2203.2 |
E. coli DNA Ligase |
M1217-100 |
Biovision |
each |
EUR 385.2 |
E. coli Exonuclease I |
M1222-100 |
Biovision |
each |
EUR 301.2 |
E. coli Exonuclease III |
M1223-100 |
Biovision |
each |
EUR 320.4 |
E. coli Recombinant IDNK |
P1050-10 |
Biovision |
each |
EUR 196.8 |
E. coli Recombinant IDNK |
P1050-50 |
Biovision |
each |
EUR 457.2 |
Recombinant E. coli, Glucokinase |
P1054-10 |
Biovision |
each |
EUR 196.8 |
Recombinant E. coli, Glucokinase |
P1054-50 |
Biovision |
each |
EUR 457.2 |
Benzonase, E. Coli Recombinant |
7680-25 |
Biovision |
each |
EUR 398.4 |
Benzonase, E. Coli Recombinant |
7680-5 |
Biovision |
each |
EUR 164.4 |
E. Coli Recombinant TRXB |
6331-100 |
Biovision |
each |
EUR 510 |
E. Coli Recombinant SlyD |
6366-100 |
Biovision |
each |
EUR 548.4 |
E. coli O157 Antibody |
V3307-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This mAb shows specificity to E. coli O157 in a simple ELISA. Escherichia coli are Gram negative bacterium that are commonly found in the lower intestine of warm-blooded organisms (endotherms). Their serological types are determined in combination with somatic antigens (O group: O1-O173) and flagella antigens (H type: H1-H56). The E. coli that cause intestinal infectious diseases including diarrhea, acute gastritis or colitis are referred to as pathogenic E. coli, which are classified into the following four groups according to differences in the mode of pathogenicity; enteropathogenic E. coli (EPEC), enteroinvasive E. coli (EIEC), enterotoxigenic E. coli (ETEC) and enterohemorrhagic E. coli (EHEC). Although the identification of pathogenic E. coli requires verification of their pathogenicity, pathogenic E. coli often have specific serotypes; therefore, typing of the serogroup and serotype is necessary in screening pathogenic E. coli. |
E. coli O157 Antibody |
V3307-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: This mAb shows specificity to E. coli O157 in a simple ELISA. Escherichia coli are Gram negative bacterium that are commonly found in the lower intestine of warm-blooded organisms (endotherms). Their serological types are determined in combination with somatic antigens (O group: O1-O173) and flagella antigens (H type: H1-H56). The E. coli that cause intestinal infectious diseases including diarrhea, acute gastritis or colitis are referred to as pathogenic E. coli, which are classified into the following four groups according to differences in the mode of pathogenicity; enteropathogenic E. coli (EPEC), enteroinvasive E. coli (EIEC), enterotoxigenic E. coli (ETEC) and enterohemorrhagic E. coli (EHEC). Although the identification of pathogenic E. coli requires verification of their pathogenicity, pathogenic E. coli often have specific serotypes; therefore, typing of the serogroup and serotype is necessary in screening pathogenic E. coli. |
E. coli O157 Antibody |
V3307SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This mAb shows specificity to E. coli O157 in a simple ELISA. Escherichia coli are Gram negative bacterium that are commonly found in the lower intestine of warm-blooded organisms (endotherms). Their serological types are determined in combination with somatic antigens (O group: O1-O173) and flagella antigens (H type: H1-H56). The E. coli that cause intestinal infectious diseases including diarrhea, acute gastritis or colitis are referred to as pathogenic E. coli, which are classified into the following four groups according to differences in the mode of pathogenicity; enteropathogenic E. coli (EPEC), enteroinvasive E. coli (EIEC), enterotoxigenic E. coli (ETEC) and enterohemorrhagic E. coli (EHEC). Although the identification of pathogenic E. coli requires verification of their pathogenicity, pathogenic E. coli often have specific serotypes; therefore, typing of the serogroup and serotype is necessary in screening pathogenic E. coli. |
E. coli Protein GrpE (GrpE) Protein |
20-abx261718 |
Abbexa |
-
EUR 4236.00
-
EUR 393.60
-
EUR 276.00
|
|
|
Human Escherichia coli (E. coli) ELISA Kit |
abx052493-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
Cow Escherichia coli (E. coli) ELISA Kit |
abx055785-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
CLIA kit for Human TPS (Tissue Polypeptide Specific Antigen) |
E-CL-H1374 |
Elabscience Biotech |
1 plate of 96 wells |
EUR 700.8 |
|
Description: A sandwich CLIA kit for quantitative measurement of Human TPS (Tissue Polypeptide Specific Antigen) in samples from Serum, Plasma, Cell supernatant |
ELISA kit for Human TPS (Tissue Polypeptide Specific Antigen) |
E-EL-H2362 |
Elabscience Biotech |
1 plate of 96 wells |
EUR 640.8 |
|
Description: A sandwich ELISA kit for quantitative measurement of Human TPS (Tissue Polypeptide Specific Antigen) in samples from Serum, Plasma, Cell supernatant |
E. Coli Proteins-Agarose affinity gel for removing E. coli antibodies |
EC11-G |
Alpha Diagnostics |
1 ml |
EUR 343.2 |
E. coli 0157:H7 cell protein |
30-AE13 |
Fitzgerald |
1 ml |
EUR 340.8 |
Description: Heat inactivated E. coli O157:H7 cells |
E. coli Syndecan 1 (SDC1) Protein |
20-abx263542 |
Abbexa |
-
EUR 994.80
-
EUR 493.20
-
EUR 644.40
|
|
|
E. coli Progesterone Receptor (PGR) Protein |
20-abx263552 |
Abbexa |
-
EUR 994.80
-
EUR 493.20
-
EUR 644.40
|
|
|
Recombinant Human RAGE Protein (E. coli) |
VAng-2906Lsx-1mg |
Creative Biolabs |
1 mg |
EUR 4316.4 |
Description: Recombinant Human RAGE (AGER) protein is expressed in E. coli. (Uniprot ID: Q15109) |
Recombinant Human RAGE Protein (E. coli) |
VAng-2906Lsx-200g |
Creative Biolabs |
200 µg |
EUR 1594.8 |
Description: Recombinant Human RAGE (AGER) protein is expressed in E. coli. (Uniprot ID: Q15109) |
Recombinant Human RAGE Protein (E. coli) |
VAng-2906Lsx-500g |
Creative Biolabs |
500 µg |
EUR 2749.2 |
Description: Recombinant Human RAGE (AGER) protein is expressed in E. coli. (Uniprot ID: Q15109) |
Recombinant CMV Protein (E. coli) [GST] |
VAng-Lsx0035-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: CMV [GST], recombinant protein from E. coli. |
Recombinant Trypanosoma Cruiz Protein (E. coli) |
VAng-Wyb8373-1mg |
Creative Biolabs |
1 mg |
EUR 4431.6 |
Description: Trypanosoma Cruiz protein, recombinant protein. |
Recombinant HIV-2 E gp 36 Protein (E. coli) |
VAng-0534Lsx-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: HIV type 2 Envelope glycoprotein 36, recombinant protein from E. coli. MW 16 kDa, 1 mg/mL. |
Deoxybrevianamide E |
D083-1MG |
TOKU-E |
1 mg |
EUR 333.6 |
Deoxybrevianamide E |
D083-5MG |
TOKU-E |
5 mg |
EUR 1076.4 |
Cytochalasin E |
C197-1MG |
TOKU-E |
1 mg |
EUR 157.2 |
Cytochalasin E |
C197-5MG |
TOKU-E |
5 mg |
EUR 462 |
Paraherquamide E |
P070-0.5MG |
TOKU-E |
0.5 mg |
EUR 480 |
Paraherquamide E |
P070-2.5MG |
TOKU-E |
2.5 mg |
EUR 1590 |
Phenelfamycin E |
P078-1MG |
TOKU-E |
1 mg |
EUR 381.6 |
Phenelfamycin E |
P078-5MG |
TOKU-E |
5 mg |
EUR 1248 |
Oligomycin E |
O021-1MG |
TOKU-E |
1 mg |
EUR 381.6 |
Oligomycin E |
O021-5MG |
TOKU-E |
5 mg |
EUR 1248 |
Roquefortine E |
R035-1MG |
TOKU-E |
1 mg |
EUR 268.8 |
Roquefortine E |
R035-5MG |
TOKU-E |
5 mg |
EUR 849.6 |
Recombinant Trypanosoma Brucei Variant-specific antigen Protein (aa 23-367) (E. coli) [His] |
VAng-Wyb8311-100g |
Creative Biolabs |
100 µg |
EUR 4002 |
Description: Trypanosoma Brucei brucei Variant-specific antigen protein, recombinant protein. |
Recombinant Trypanosoma Brucei Variant-specific antigen Protein (aa 23-367) (E. coli) [His] |
VAng-Wyb8311-500g |
Creative Biolabs |
500 µg |
EUR 9794.4 |
Description: Trypanosoma Brucei brucei Variant-specific antigen protein, recombinant protein. |
Recombinant Plasmodium Falciparum GTP-binding nuclear protein Ran Protein (aa 1-214) (E. coli) |
VAng-Wyb6469-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Plasmodium Falciparum GTP-binding nuclear protein Ran, recombinant protein. |
E. coli Chaperone Protein Dnaj (DNAJ) Protein |
20-abx260479 |
Abbexa |
-
EUR 276.00
-
EUR 2798.40
-
EUR 393.60
|
|
|
E. coli Chaperone Protein SKP (SKP) Protein |
20-abx260554 |
Abbexa |
-
EUR 3433.20
-
EUR 393.60
-
EUR 276.00
|
|
|
E. coli Green Fluorescent Protein (GFP) Protein |
20-abx260632 |
Abbexa |
-
EUR 276.00
-
EUR 3650.40
-
EUR 393.60
|
|
|
Purified Rec. E. Coli Thioredoxin (TrxA, E. coli) (fusion protein) for WB +ve control |
THRX11-C |
Alpha Diagnostics |
100 ul |
EUR 343.2 |
E. coli DNA Primase Assay Kit Plus (E. coli primase-helicase included) |
EGA100KE |
ProFoldin |
100 assays |
EUR 444.91 |
Description: This product includes all the kit components in E. coli DNA Primase Assay Kit (Catalog No. EGA100K ) plus 45 ul of 100 x E. coli primase-helicase complex. It is for 100 assays of E.coli DNA primase reactions in a 96-well plate format or 200 assays in 384-well assay format. |
E. coli RNA polymerase Assay Kit Plus (E. coli RNA polymerase included) |
RPA100KE |
ProFoldin |
100 assays |
EUR 467.15 |
Description: This product includes all the reagents in E. coli RNA Polymerase Assay Kit (Catalog number RPA100K) plus the enzyme, 33 ul of 100 x E. coli RNAP. It is for 100 assays of E. coli RNA polymerase reactions in a 384-well assay format. |
Escherichia coli Serotype O2 (E. coli O2) Antibody |
abx411330-02mg |
Abbexa |
0.2 mg |
EUR 678 |
|
Escherichia coli Serotype O15 (E. coli O15) Antibody |
abx411331-02mg |
Abbexa |
0.2 mg |
EUR 678 |
|
Escherichia coli Serotype O20 (E. coli O20) Antibody |
abx411332-02mg |
Abbexa |
0.2 mg |
EUR 678 |
|
E. coli O157 antibody (FITC) |
61C-CR1295M1F |
Fitzgerald |
100 ug |
EUR 489.6 |
Description: Mouse monoclonal E. coli O157 antibody (FITC) |
E. coli O157 antibody (FITC) |
61C-CR1295M4F |
Fitzgerald |
100 ug |
EUR 561.6 |
Description: Mouse monoclonal E. coli O157 antibody (FITC) |
E. coli O157:H7 antibody |
70-XG13 |
Fitzgerald |
1 mg |
EUR 734.4 |
Description: Affinity purified Goat polyclonal E. coli O157:H7 antibody. |
E. coli antibody (K99 Pilus) |
10-E20A |
Fitzgerald |
500 ug |
EUR 591.6 |
Description: Mouse monoclonal E. coli antibody (K99 Pilus) |
E. coli Tryptophanase (Tnase) Antibody |
33517-05111 |
AssayPro |
150 ug |
EUR 313.2 |
E. coli Glycerol Kinase Antibody |
32699-05111 |
AssayPro |
150 ug |
EUR 313.2 |
Mouse antibody for E. coli |
1063 |
Virostat |
100 ug |
EUR 438.46 |
Description: This is Mouse monoclonal FITC conjugated antibody against E coli O157 for WB, ELISA. |
E. coli RecQ DNA helicase |
01-003 |
Sceti |
50 ug |
EUR 574.8 |
Description: The E. coli RecQ DNA helicase is available in Europe and for worldwide shipping via Gentaur. |
E. coli RecQ DNA helicase |
01-004 |
Sceti |
250? g |
EUR 1858.8 |
Description: The E. coli RecQ DNA helicase is available in Europe and for worldwide shipping via Gentaur. |
E. coli Enterotoxin B Antibody |
abx021678-1mg |
Abbexa |
1 mg |
EUR 718.8 |
|
E. coli Enterotoxin B Antibody |
abx021679-1mg |
Abbexa |
1 mg |
EUR 727.2 |
|
E. coli Enterotoxin B Antibody |
abx021680-1mg |
Abbexa |
1 mg |
EUR 718.8 |
|
E. coli O157 Antibody (FITC) |
abx021683-1mg |
Abbexa |
1 mg |
EUR 2798.4 |
|
E. coli O157:H7 Antibody |
abx022980-1mg |
Abbexa |
1 mg |
EUR 718.8 |
|
E. coli Enterotoxin LT Antibody |
abx023834-1mg |
Abbexa |
1 mg |
EUR 878.4 |
|
E. coli Enterotoxin LT Antibody |
abx023835-1mg |
Abbexa |
1 mg |
EUR 878.4 |
|
E. coli Enterotoxin LT Antibody |
abx023836-1mg |
Abbexa |
1 mg |
EUR 878.4 |
|
E. coli Enterotoxin LT Antibody |
abx023837-1mg |
Abbexa |
1 mg |
EUR 878.4 |
|
E. coli Enterotoxin STp Antibody |
abx023838-1mg |
Abbexa |
1 mg |
EUR 1053.6 |
|
E. coli Enterotoxin STp Antibody |
abx023839-1mg |
Abbexa |
1 mg |
EUR 1053.6 |
|
E. coli Enterotoxin STp Antibody |
abx023840-1mg |
Abbexa |
1 mg |
EUR 1053.6 |
|
rHu BMP-2 (E. coli) |
AK8356-0100 |
Akron Biotech |
100µg |
Ask for price |
E. coli O157 (9.88) Antibody |
BNC040207-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),CF405S conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNC040207-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),CF405S conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNC050207-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),CF405M conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNC050207-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),CF405M conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNCAP0207-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNCAP0207-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNCB0207-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),Biotin conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNCB0207-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),Biotin conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNCP0207-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against E. coli O157 (9.88),PerCP conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNCR0207-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against E. coli O157 (9.88),RPE conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNC940207-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),CF594 conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNC940207-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),CF594 conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNCA0207-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against E. coli O157 (9.88),APC conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNC810207-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),CF680R conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNC810207-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),CF680R conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNUB0207-100 |
Biotium |
100uL |
EUR 250.8 |
Description: Primary antibody against E. coli O157 (9.88), Concentration: 0.2mg/mL |
E. coli O157 (9.88) Antibody |
BNUB0207-500 |
Biotium |
500uL |
EUR 549.6 |
Description: Primary antibody against E. coli O157 (9.88), Concentration: 0.2mg/mL |
E. coli O157 (9.88) Antibody |
BNCH0207-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNCH0207-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNC880207-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),CF488A conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNC880207-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),CF488A conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNC680207-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),CF568 conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNC680207-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),CF568 conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNC470207-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),CF647 conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNC470207-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),CF647 conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNC430207-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),CF543 conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNC430207-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),CF543 conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNC610207-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),CF660R conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNC610207-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),CF660R conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNC800207-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),CF680 conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNC800207-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),CF680 conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNC400207-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),CF640R conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNC400207-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),CF640R conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNC550207-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),CF555 conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNC550207-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),CF555 conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNC700207-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against E. coli O157 (9.88),CF770 conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNC700207-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against E. coli O157 (9.88),CF770 conjugate, Concentration: 0.1mg/mL |
E. coli O157 (9.88) Antibody |
BNUM0207-50 |
Biotium |
50uL |
EUR 474 |
Description: Primary antibody against E. coli O157 (9.88), 1mg/mL |
Recombinant Diacylglycerol Kinase (E. coli) |
MET-5035 |
Cell Biolabs |
100 mg |
EUR 331.2 |
Description: Purified recombinant prokaryotic DAG kinase expressed in E. coli |
Recombinant Diacylglycerol Kinase (E. coli) |
MET-5035-5 |
Cell Biolabs |
5 x 100 mg |
EUR 1104 |
Description: Purified recombinant prokaryotic DAG kinase expressed in E. coli |
E. coli DNA Polymerase I |
M1210-100 |
Biovision |
each |
EUR 307.2 |
E. coli Recombinant Carbonic anhydrase |
P1049-10 |
Biovision |
each |
EUR 196.8 |
E. coli Recombinant Carbonic anhydrase |
P1049-50 |
Biovision |
each |
EUR 457.2 |
Insulin, human recombinant (E. coli) |
4772-25 |
Biovision |
each |
EUR 542.4 |
Insulin, human recombinant (E. coli) |
4772-5 |
Biovision |
each |
EUR 248.4 |
E. Coli Recombinant Thioredoxin 1 |
6329-50 |
Biovision |
each |
EUR 483.6 |
CLPP, His-Tag (E. coli) |
100991 |
BPS Bioscience |
50 µg |
EUR 395 |
Description: Recombinant E. coli CLPP (ATP-dependent Clp protease proteolytic subunit) encompassing amino acids 15-207 (end). This construct contains an N-terminal His-tag (6xHis). The recombinant protein was affinity purified. |
Human VEGF165 (E. coli derived) |
79516 |
BPS Bioscience |
10 µg |
EUR 215 |
Description: Recombinant human vascular endothelial growth factor (VEGF)165 expressed in E. coli cells. Human VEGF exists in multiple molecular variants and are named based on the number of amino acids they contain. VEGF165 is the most common form of VEGF. It is a 38.2 kDa disulfide-linked homodimeric protein consisting of two 165 amino acid polypeptides. |
Recombinant Nucleosome (E. coli-derived) |
52038 |
BPS Bioscience |
100 µg |
EUR 505 |
Description: Human recombinant nucleosomes_x000D_consisting of 147 bp DNA (PCR) and 2 molecules_x000D_each of histones H2A (a.a. 2-130(end)), H2B_x000D_(a.a. 2-126(end)), H3 (a.a. 2-137(end)), and H4_x000D_(a.a. 2-103(end)), expressed in an E. coli_x000D_expression system. GenBank Accession Nos. are_x000D_NM_033445, NM_003528, NM_003532, and_x000D_NM_003548, respectively. Each histone protein_x000D_has an N-terminal His-tag. Total histone MW =_x000D_113.8 kDa. |
Recombinant Nucleosome (E. coli-derived) |
52038-1 |
BPS Bioscience |
100 µg |
EUR 505 |
Description: Recombinant human nucleosome consisting of 147 bp DNA (PCR) and 2 molecules each of histones H2A, encompassing amino acids 2-130(end), H2B encompassing amino acids 2-126(end), H3 encompassing amino acids 2-137(end), and H4 encompassing amino acids 2-103(end). Each histone construct contains an N-terminal His-tag (6xHis). The recombinant complex was affinity purified. |
Recombinant Nucleosome (E. coli-derived) |
52038-2 |
BPS Bioscience |
1 mg |
EUR 3130 |
Description: Recombinant human nucleosome consisting of 147 bp DNA (PCR) and 2 molecules each of histones H2A, encompassing amino acids 2-130(end), H2B encompassing amino acids 2-126(end), H3 encompassing amino acids 2-137(end), and H4 encompassing amino acids 2-103(end). Each histone construct contains an N-terminal His-tag (6xHis). The recombinant complex was affinity purified. |
Small Nuclear Ribonucleoprotein Polypeptide E Protein |
20-abx263278 |
Abbexa |
-
EUR 276.00
-
EUR 1930.80
-
EUR 393.60
|
|
|
Mouse Anti-E. coli and LPS IgG1 Monoclonal Antibody, Clone 1C6 |
7098 |
Chondrex |
1 mg/ml x 0.1 ml |
EUR 578.52 |
Description: Mouse Anti-E. coli and LPS IgG1 Monoclonal Antibody |
Mouse Anti-E. coli and LPS IgG2a Monoclonal Antibody, Clone 1E1 |
7099 |
Chondrex |
1 mg/ml x 0.1 ml |
EUR 578.52 |
Description: Mouse Anti-E. coli and LPS IgG2a Monoclonal Antibody |
Mouse Anti-E. coli and LPS IgG2b Monoclonal Antibody, Clone 2H10 |
7100 |
Chondrex |
1 mg/ml x 0.1 ml |
EUR 578.52 |
Description: Mouse Anti-E. coli and LPS IgG2b Monoclonal Antibody |
Recombinant Trypanosoma Brucei Proliferating cell nuclear antigen Protein (aa 21-292) (E. coli) [His] |
VAng-Wyb8157-100g |
Creative Biolabs |
100 µg |
EUR 4002 |
Description: Trypanosoma Brucei gambiense Proliferating cell nuclear antigen protein, recombinant protein. |
Recombinant Trypanosoma Brucei Proliferating cell nuclear antigen Protein (aa 21-292) (E. coli) [His] |
VAng-Wyb8157-500g |
Creative Biolabs |
500 µg |
EUR 9794.4 |
Description: Trypanosoma Brucei gambiense Proliferating cell nuclear antigen protein, recombinant protein. |
Recombinant Trypanosoma Cruzi Proliferating cell nuclear antigen Protein (aa 24-289) (E. coli) [His] |
VAng-Wyb8466-100g |
Creative Biolabs |
100 µg |
EUR 4002 |
Description: Trypanosoma Cruzi Proliferating cell nuclear antigen protein, recombinant protein. |
Recombinant Trypanosoma Cruzi Proliferating cell nuclear antigen Protein (aa 24-289) (E. coli) [His] |
VAng-Wyb8466-500g |
Creative Biolabs |
500 µg |
EUR 9794.4 |
Description: Trypanosoma Cruzi Proliferating cell nuclear antigen protein, recombinant protein. |
Recombinant (E. coli) Human neuron-specific enolase (NSE/gamma enolase) protein control for western |
NSE11-C |
Alpha Diagnostics |
100 ul |
EUR 343.2 |
Right here we current an expedited methodology for producing laboratory-grade TEV protease in E. coli utilizing a freeze-thaw methodology, adopted by purification with immobilized metallic affinity chromatography. Protease is obtained by expression from the pDZ2087 plasmid in BL21 (DE3) cells. Proteolysis ensuing from this product, cleaves a maltose-binding protein fusion to completion at a fusion-to-protease molar ratio of 50:1.
Leave a Comment